Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$IKT

Inhibikase Therapeutics, Inc. Common Stock

XNAS

$2.17+10.77%+$0.2111Prev $1.96LIVE Full chart Live alerts
No recent price bars, the chart lights up when IKT starts printing.

As of the latest tick, IKT is trading at $2.17, up 10.77% versus the previous close of $1.96.

Key Stats

Price
$2.17
Change today
+10.77%
Previous close
$1.96
52-week range
$1.33 – $2.26
Avg daily volume
800K
Exchange
XNAS

Why is $IKT up today?

13 alerts today111.4x RVOL

IKT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 13 unusual-volume and momentum alerts on IKT today, peaking at 111.4x its normal volume.

Auto-generated from live scanner data. Not investment advice.

$IKT Sentiment

Bullish
Bearish100Bullish
📰 News: 3 bull · 0 bearToday: +10.8%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$IKT Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 32m ago +1.4% vs EMA
$IKT near 200 EMA: +1.41% from 200 EMA at 12:25 PM ET
at $2.20
Alert· 33m ago +2.02%
$IKT moved +2.02% in 1 min (Level 1) at 12:25 PM ET
at $2.20
Alert· 33m ago 96.3× RVOL
IKT hit 96.280x RVOL at 12:25 PM ET
at $2.20
Alert· 38m ago
The Watcher (dev) BOUGHT $IKT at $2.2200 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher breakout strategy","reason":"double_bottom · lows $1.93 · neckline $2.14 · tgt $2.84 · R/R 2.00","gameTradeId":"a78e1297-1e19-4f5b-b443-c420075862e2","entryPrice":2.22,"shares":1,"positionSizePct":0.2215,"rvolContext":2.3477576867846803,"stopRule":"Watcher exits: chandelier −3×ATR · hard stop −1.5×ATR · 60d hold cap","instance":"WatcherPaper"}
at $2.22
Alert· 58m ago
The Watcher BOUGHT $IKT at $1.9600 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher breakout strategy","reason":"double_bottom · lows $1.93 · neckline $2.14 · tgt $2.10 · R/R 2.45","gameTradeId":"d1ecdf26-0a9b-418d-90ae-00a276a89be1","entryPrice":1.96,"shares":2.5510204081632653,"positionSizePct":0.5,"rvolContext":0.4961534066178817,"stopRule":"Watcher exits: chandelier −3×ATR · hard stop −1.5×ATR · 60d hold cap","instance":"Watcher"}
at $1.96
Alert· 1h ago 111.4× RVOL
IKT hit 111.440x RVOL at 11:57 AM ET
at $2.25
Alert· 1h ago +2.64%
$IKT moved +2.64% in 1 min (Level 1) at 11:39 AM ET
at $2.33
Alert· 1h ago 23.6× RVOL
IKT hit 23.637x RVOL at 11:39 AM ET
at $2.29
Alert· 1h ago +1.58%
$IKT moved +1.58% in 1 min (Level 1) at 11:10 AM ET
at $2.25
Alert· 1h ago 24.4× RVOL
IKT hit 24.430x RVOL at 11:10 AM ET
at $2.23
Alert· 2h ago +3.14%
$IKT moved +3.14% in 1 min (Level 1) at 10:28 AM ET
at $2.15
Alert· 3h ago +3.27%
$IKT moved +3.27% in 1 min (Level 1) at 9:32 AM ET
at $2.08
Alert· 3h ago 2.8× RVOL
IKT hit 2.792x RVOL at 9:32 AM ET
at $2.08
Alert· 4h ago -13.37%
$IKT moved -13.37% in 1 min (Level 5) at 8:00 AM ET
at $1.78
Alert· 3d ago +2.0% vs EMA
IKT 200EMA (1m) Trending · 69 bars · L3 · +1.99% above EMA · slope +0.33%
at $2.04
Alert· 4d ago 21.3× RVOL
IKT hit 21.324x RVOL at 11:04 AM ET
at $1.95
Alert· 4d ago +0.8% vs EMA
IKT 50EMA (1m) Trending · 59 bars · L3 · +0.84% above EMA · slope +0.68%
at $2.02
Alert· 4d ago 12.8× RVOL
IKT hit 12.819x RVOL at 1:50 PM ET
at $2.00
News· GlobeNewswire Inc.· 55d ago Bullish
Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
News· GlobeNewswire Inc.· 101d ago Neutral
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News· GlobeNewswire Inc.· 235d ago Neutral
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
News· GlobeNewswire Inc.· 382d ago Bullish
BIK-Datenanalyse zeigt: Die Aufnahme von BNPL-Transaktionsdaten in die Kredithistorie könnte fast jedem zweiten „Thin-file-Kunden“ helfen, seine Kreditwürdigkeit zu verbessern
News· Investing.com· 570d ago Bullish
Top 10 Small-Cap Stocks to Watch in 2025
News· GlobeNewswire Inc.· 757d ago
Inhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s Disease
News· GlobeNewswire Inc.· 769d ago
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
News· GlobeNewswire Inc.· 785d ago
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 Million
Free alerts

Get free $IKT alerts the moment volume spikes

Our scanner flagged $IKT 15 times in the last 30 days. Create a free account to track $IKT, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

IKT stock FAQ

Why is $IKT up today?

IKT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 13 unusual-volume and momentum alerts on IKT today, peaking at 111.4x its normal volume.

What is the IKT stock price today?

IKT last traded at $2.17, up 10.77% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live IKT alerts?

The IKT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IKT 15 times in the last 30 days.

What exchange is IKT on?

IKT (Inhibikase Therapeutics, Inc. Common Stock) trades on XNAS.

Is IKT good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IKT for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.